Schechter Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$991K Buy
11,024
+4,082
+59% +$365K 0.08% 239
2024
Q4
$555K Buy
6,942
+2,252
+48% +$195K 0.04% 365
2024
Q3
$422K Sell
4,690
-851
-15% -$71.6K 0.03% 431
2024
Q2
$436K Buy
5,541
+8
+0.1% +$656 0.03% 402
2024
Q1
$482K Sell
5,533
-144
-3% -$12.3K 0.04% 379
2023
Q4
$468K Sell
5,677
-1,041
-15% -$79.3K 0.04% 364
2023
Q3
$526K Sell
6,718
-508
-7% -$42.5K 0.05% 330
2023
Q2
$637K Buy
7,226
+137
+2% +$11.8K 0.06% 329
2023
Q1
$572K Buy
+7,089
New +$578K 0.05% 381
2022
Q4
Sell
-5,187
Closed -$419K 878
2022
Q3
$419K Buy
5,187
+2,749
+113% +$247K 0.04% 563
2022
Q2
$220K Sell
2,438
-9,301
-79% -$942K 0.02% 818
2022
Q1
$1.3M Buy
11,739
+3,261
+38% +$345K 0.12% 213
2021
Q4
$877K Buy
+8,478
New +$982K 0.08% 351

Other funds holding MDT

Schechter Investment Advisors's MDT Position: Q1 2025 in Review

Schechter Investment Advisors increased its Medtronic (MDT) stake by 59% in Q1 2025, buying an estimated $365K and bringing the position to 11,024 shares worth $991K. The position accounts for 0.08% of the portfolio, ranked #239.

Schechter Investment Advisors first reported a position in MDT in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.3M in Q1 2022. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Schechter Investment Advisors held 11,024 shares of Medtronic worth $991K as of Q1 2025.
  • Schechter Investment Advisors bought 4,082 Medtronic shares in Q1 2025, an estimated $365K.
  • Medtronic made up 0.08% of Schechter Investment Advisors's portfolio in Q1 2025, its #239 holding.
  • Schechter Investment Advisors first reported a position in Medtronic in Q4 2021 and has held it in 13 quarters since.
  • Schechter Investment Advisors's Medtronic position peaked at $1.3M in Q1 2022.
  • 2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Schechter Investment Advisors's 13F filing for Q1 2025, filed 1 May 2025.